Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2025-12-24 @ 2:55 PM
NCT ID:
NCT02893059
Eligibility Criteria:
Inclusion Criteria:
* incident and prevalent cases of patients with type I or type II diabetes. arthritis:
* incident and prevalent cases of rheumatoid arthritis patients defined according to the ACR-EULAR criteria 2010 (Aletaha D et al, 2010).
Renal failure :
• incident and prevalent cases of patients with kidney disease stage 3 or 4, transplanted or not.
Prostate cancer :
• Incident cases of patients with prostate cancer regardless of the stage at diagnosis (positive prostate biopsy).
Breast cancer :
• Incident cases of patients with breast cancer regardless of the stage at diagnosis (biopsy positive breast).
Colorectal cancer :
• Incident cases of patients with colorectal cancer regardless of the stage at diagnosis (colonoscopy and polyp biopsy positive).
Exclusion Criteria:
\- The subject participates in an experimental study of research affecting the therapeutic management of the patient.
* The subject is exclusion period determined by a previous study.
* The subject is under judicial protection, guardianship or curatorship.
* It is not possible to give informed about information
* The subject does not read French and is not autonomous filling a questionnaire.
* The patient has psychiatric disorders.
* The subject is an emergency.
* Monitoring between patient visits than 6 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02893059
Study Brief:
Protocol Section:
NCT02893059